CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended				9 Months Ended		10 Months Ended	12 Months Ended
	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2018	Dec. 31, 2019
Cash flows from operating activities:
Net income (loss)	$ 1,546,209	$ (719,840)	$ (556,914)	$ (124,907)	$ 1,232,927	$ (1,853,544)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization					162,127	320,388
Amortization of debt discount on notes payable					361,193	217,336
Amortization of right of use assets					987,542	784,204
Share-based payment compensation					11,392	28,582
Provision for (recovery of) returns and doubtful accounts					70,932	(128,628)
Deferred income taxes (benefit)					(5,485)	0
Changes in operating assets and liabilities:
Accounts receivable					(138,271)	1,778,241
Prepaid expenses and other current assets					249,383	(173,775)
Contract assets					432,204	79,192
Inventory					15,713	(89,843)
Other assets					(254)	(782,802)
Accounts payable					(571,231)	487,202
Accrued expenses and other long-term liabilities					(589,952)	45,039
Operating lease liabilities					(1,204,155)	(980,937)
Deferred revenue					(1,317,239)	(1,163,169)
Net cash provided by (used in) operating activities					(303,174)	(1,432,514)
Cash flows from investing activities:
Purchases of property and equipment					0	(175,139)
Security deposits					(125)	33,815
Purchase of intangible assets					(63,005)	(46,674)
Net cash provided by (used in) investing activities					(63,130)	(187,998)
Cash flows from financing activities:
Proceeds from issuance of PPP loan					754,000	0	$ 1,000,000	$ 1,000,000
Repayment of short-term debt					(1,000,000)	0
Repayment of long-term debt					0	(489,321)		(489,321)
Net cash provided by (used in) financing activities					(246,000)	(489,321)
Effect of exchange rate changes on cash and cash equivalents					8,419	10,557
Net increase (decrease) in cash and cash equivalents					(603,885)	(2,099,276)
Cash and cash equivalents, beginning of period		1,475,166		3,059,677	1,475,166	3,059,677		3,059,677
Cash and cash equivalents, end of period	871,281		960,401		871,281	960,401	$ 3,059,677	$ 1,475,166
Supplemental disclosures:
Cash paid for interest					261,095	176,008
Non-cash investing and financing activities:
Undistributed Series A redeemable convertible preferred stock dividends					812,362	770,027
Accretion of Series A redeemable convertible preferred stock	$ 175,335	$ 26,090	$ 139,399	$ 129,239	$ 366,566	$ 402,861